Single-use advantage Markets opportunities around sterile, single-use spinal instrumentation and implants to reduce infection risk, lower SPD costs, and minimize readmission penalties for health systems.

Global expansion potential Although ALTUM is not US-available yet, there is a pathway to enter large US and international markets with minimally invasive pedicle osteotomy solutions and sterilized kit concepts.

Cost efficiency emphasis Highlight total cost of ownership reductions through sterile kits and streamlined workflows to procurement teams and spine centers seeking budget certainty and supply chain resilience.

Strategic partnerships Target hospitals, ASC networks, and distributor partners that emphasize infection control, surgical efficiency, and standardization of instrumentation to accelerate adoption of TRUE Spinal Fixation and Altum systems.

Tech and training Leverage digital presence and educational support to drive trials and demonstrations, focusing on surgeon-friendly, robust, and sterile design to differentiate from reusable systems.